From July 1, 2022 to December 31, 2022, the company has repurchased 4,867,306 shares, representing 2% for $697.3 million. With this, the company has completed the repurchase of 6,945,513 shares, representing 2.85% for $1,000 million under the buyback announced on March 31, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
88.01 USD | -0.54% | +2.09% | -16.42% |
Apr. 23 | BIONTECH : Gets a Neutral rating from Deutsche Bank | ZD |
Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.42% | 21.33B | |
-1.75% | 105B | |
+3.64% | 97.5B | |
+1.86% | 22.19B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-21.23% | 14.52B | |
+4.99% | 14.09B | |
+21.85% | 10.99B | |
-23.63% | 8.63B |
- Stock Market
- Equities
- BNTX Stock
- News BioNTech SE
- Tranche Update on BioNTech SE's Equity Buyback Plan announced on March 31, 2022.